Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01937507 · ClinicalTrials.gov registry record · Phase 2
Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer
A Phase 2 study, sponsored by Western Regional Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT01937507: Clinical Trial Phase 2 study, sponsored by Western Regional Medical Center.
NCT01937507 is a Phase 2 study that was terminated before completion, run by Western Regional Medical Center. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01937507, a Phase 2 study, was terminated before completion, sponsored by Western Regional Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
Deliver oxliplatin and 5-FU via HAI to breast cancer patients with liver-only or liver-predominant metastases who have failed at least one line of systemic chemotherapy in metastatic setting.
Primary Outcome
To determine response rate (RR) of HAI with oxaliplatin/5-FU every three weeks in heavily pre-treated patients with advanced breast cancer with metastasis to the liver.
Interventions
- DRUG HAI with FOLFOX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
Why NCT01937507 stopped before completion
NCT01937507 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which HAI with FOLFOX is the first listed.
NCT01937507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01937507 about?
NCT01937507 is a clinical study titled "Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer". Deliver oxliplatin and 5-FU via HAI to breast cancer patients with liver-only or liver-predominant metastases who have failed at least one line of systemic chemotherapy in metastatic setting.
What is the current status of trial NCT01937507?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2012-12. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01937507?
The interventions under investigation include: HAI with FOLFOX (DRUG).
Who is sponsoring clinical trial NCT01937507?
This trial is sponsored by Western Regional Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01937507's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia